WPRIM Management System> DCMS> Osteoporosis and Sarcopenia> 2021> 7> 3

Volume: 7 Issue: 3

1. Intervention thresholds to identify postmenopausal women with high fracture risk: A single center study based on the Philippines FRAX model Page:98—102
2. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture Page:115—120
3. Prevalence of osteoporosis in elderly women in Hong Kong Page:92—97
4. Romosozumab and cardiovascular safety in Japan Page:89—91
5. Osteoporosis treatment rates after hip fracture 2011e2019 in Hawaii:Undertreatment of men after hip fractures Page:103—109
6. Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study Page:110—114
7. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture Page:115—120
8. Intervention thresholds to identify postmenopausal women with high fracture risk: A single center study based on the Philippines FRAX model Page:98—102
9. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture Page:115—120
10. Prevalence of osteoporosis in elderly women in Hong Kong Page:92—97
11. Romosozumab and cardiovascular safety in Japan Page:89—91
12. Osteoporosis treatment rates after hip fracture 2011e2019 in Hawaii:Undertreatment of men after hip fractures Page:103—109
13. Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with severe osteoporosis: An open-label, randomized, pilot study Page:110—114
14. Musculoskeletal ambulation disability symptom complex as a risk factor of incident bone fragility fracture Page:115—120